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Dietary antioxidant supplementation has been popular in Western countries. Various supplements
have been developed in recent years, and research has been gathered from both animal and clinical
research trials. In this review, the therapeutic value of oral administration of a combination of melon
superoxide dismutase (SOD) and a vegetable polymer (gliadin) is evaluated. Critical examination of
the effects of SOD–gliadin supplementation is carried out, with an emphasis on its impact on
oxidative stress levels and on endogenous antioxidant pathways. Overall analysis of peer-reviewed
published data suggests that intake of SOD–gliadin might have advantageous health effects. These
conclusions are dependent on the condition or pathology under consideration. In general, the au-
thors,who analyzed SOD-gliadin supplementation, support the use of SOD–gliadin supplementation
as a complementary treatment rather than a therapeutic treatment. To further clarify the importance
of dietary SOD–gliadin administration, additional large-scale clinical trials are recommended.
 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).   Introduction
The availability of oxygen determines the evolution of com-
plex multicellular organisms. However, oxygen metabolism also
generates toxic byproducts called reactive oxygen species (ROS).
ROS can cause cellular damage through the oxidation of several
essential molecules such as proteins, lipids, or DNA. This is a
paradox of aerobic life; although oxygen is an absolute necessity,
oxidation is the necessary consequence.
ROS comprise all chemically reactive molecules derived from
oxygen. Superoxide anion (O2 ) is the product of a one-electron
reduction of molecular oxygen (O2) and the precursor of all other
ROS. Because it is both an anion and a free radical, O2  is a very
short-livedmolecule that can only cross cell membranes through
anionic channels. In biological systems, O2  diffusion is limited
by its rapid dismutation into hydrogen peroxide (H2O2) by SOD
enzymes [1] or by its combination with nitric oxide to form
peroxynitrite [2]. Therefore, O2  probably does not cause direct
cellular oxidative damage but is certainly crucial to propagate
oxidative chain reactions involving highly cytotoxicmolecules. In
humans, 1% to 3% of all O2 consumed by the body is transformedd by Isocell Nutra, which
nts (GliSODin).
: þ41 44 635 6883.
nc. This is an open access articleinto O2 [3]. There are three main in vivo sources for O2
formation: 1) mitochondrial respiratory chain complexes [4], 2)
nicotinamide adenine dinucleotide phosphate-oxidase (NOX)
enzymes [5], and 3) xanthine oxidases [6] (Fig. 1). Although all
eukaryotic cells depend on mitochondrial activity, only phago-
cytes and endothelial cells express NOX enzymes. In this case,
ROS are primarily used as defense mechanisms against in-
vading pathogens, through release into specialized degradative
compartments.
In recent years, increasing evidence demonstrated that in
addition to their cytotoxic activity, ROS perform a regulatory
function in cellular homeostasis [7]. Redox signaling, distinct
from oxidative damage, is associated with low concentrations
of oxidants that reversibly modify speciﬁc cell targets to
transduce a message [8]. To determine which ROS function
will act in a certain cellular context, cells manage a delicate
oxidation balance. To achieve the appropriate redox stoichi-
ometry, complex protective mechanisms have evolved for
controlling the levels of ROS rather than completely elimi-
nating them. Antioxidant activity can occur by direct scav-
enging of ROS, by limiting the production of oxidants, or by
increasing antioxidant defenses in the cell [9]. Antioxidants
such as SOD, catalase (CAT) or glutathione peroxidase (GPx)
can be synthesized in vivo, and some nonenzymatic antioxi-
dants can be ingested through the diet (e.g., b-carotene or a-
tocopherol) [9].under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
Fig. 1. Schematic representation showing a possible enzymatic cascade for trans-
formation of molecular oxygen (O2) in eukaryotic cells. Enzymatic conversion of O2
into superoxide anion (O2 ) can be carried out by the mitochondrial respiratory
complexes, by NADPH oxidase or by xanthine oxidases. Superoxide dismutases are
responsible for further transformation of O2  to H2O2. Finally, enzymes such as
catalase or glutathione peroxidases are capable of converting H2O2 into H2O and O2.
H2O2, hydrogen peroxide; NADPH, nicotinamide adenine dinucleotide phosphate.
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foods such as fruits and vegetables correlates to an overall pos-
itive health status [10]. Broad acceptance of this relationship has
been responsible for the steady growth of the dietary supple-
ment industry. However, one must be cautious when analyzingthe effectiveness of such compounds, especially in a therapeutic
context. Many clinical trials have failed to demonstrate that
supplementationwith direct-acting antioxidants, especially with
the antioxidant vitamin family, could protect against disease.
One possible explanation for these disappointing results is
connected to a reduced bioavailability or absence of sustained
long-term activity of orally administered antioxidants [9].
Alternatively, supplementation with antioxidants might simply
perturb the important physiological redox balance and affect
normal cellular function [11].
The purpose of this review was to summarize research data
published in the last decade on the effects of oral supplementation
with plant-derived SOD. Speciﬁcally, I focused on a formulation
that uses cantaloupe melon–derived SOD combined with gliadin
from wheat extract. The potential beneﬁts of SOD–gliadin on
steady-state and pathologic settings are described here.
Superoxide dismutase
The SOD enzyme catalyzes the conversion of O2  to H2O2
and O2, and is ubiquitous in every aerobic organism, from bac-
teria to humans. Biochemists Joe McCord and Irwin Fridovich
were the ﬁrst to discover its enzymatic activity and to suggest its
essential role in protecting organisms against damage by ROS
[12]. SOD is a metalloenzyme, and depending on the particular
form of the enzyme, requires cofactors copper and zinc, man-
ganese, iron, or nickel. There are three isoforms of SOD in
humans: a cytosolic copper-zinc-SOD (SOD1), a mitochondrial
manganese-SOD (SOD2), and an extracellular copper-zinc-SOD
(SOD3) [1]. Because H2O2 is a coproduct of SOD catalysis and is
itself a ROS, the isolated activity of SOD cannot be viewed as
antioxidant, but rather as pro-oxidant. However, the accumula-
tion of H2O2 was linked to up-regulation of key antioxidant en-
zymes such as CAT and GPx (Fig. 1) [13,14]. Therefore, it was
proposed that increased SOD activity could stimulate other
antioxidant enzymes by enhancing oxidative stress signals [15,
16]. In this context, because SOD is not consumed upon detoxi-
ﬁcation of ROS, supplementation with SOD seems to be advan-
tageous over nonenzymatic antioxidants such as vitamins,
carotenoids, and thiols. It might also trigger the endogenous
antioxidant machinery.
Interestingly, SOD supplementation efﬁcacy seems to depend
on the source of the enzyme. For example, in a mouse model,
murine SOD is less likely to have an effect compared with SOD
from another species. In a study comparing human, bovine, and
rat SOD in a rat experimental model, the human and bovine
enzymes, despite presenting similar biochemical properties,
conferred much higher pharmacologic activity [17]. Therefore,
treatment of human disorders with human enzymewill probably
also not yield any beneﬁcial effects. Classically, bovine SOD was
used for experimental research [12] as well as in early clinical
trials to test SOD administration effects on several human dis-
orders [18,19]. With the outbreak of Creutzfeldt-Jacob disease,
bovine-derived products for human consumption were limited,
and suitable alternatives were developed from plant-extracted
forms of SOD. In this context, a variety of nongenetically modi-
ﬁed cantaloupe melon (Cucumis melo L.C.) presents particularly
high levels of SOD (100 U/mg) and a lesser extent of other
antioxidant elements (e.g., 10 U/mg CATand 1 U/mg GPx) [20,21],
which makes it an appropriate source for this enzyme.
Since 2000, melon extract with naturally enriched SOD has
been developed for use as a dietary supplement. However, due to
the low pH and high proteolytic activity in the digestive tract,
oral administration of the SOD enzyme alone renders it
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study was conducted that assessed the enzymatic activity of free
melon-derived SOD in a mediummimicking the digestive milieu
[15]. To circumvent this bioavailability problem, several research
groups designed different coatings to encapsulate SOD, mainly
using lipids and proteins. Liposomal encapsulation was one of
the ﬁrst strategies successfully applied to protect bovine SOD
from inactivation. As tested previously [22], the maximum
bioavailability after ingestion of liposomal-encapsulated SOD
increased up to fourfold. Speciﬁc formulations with melon
extract also can be found in the literature. The most extensively
studied SOD coating is wheat-derived gliadin (Tables 1 and 2).
Importantly, wheat gliadin was shown to protect SOD from
gastric degradation [15] while simultaneously displaying
bio-adhesion properties [23]. This change in bio-adhesion could
potentially enhance the adherence of the enzyme to the
epithelium of the small intestine, thus prolonging SOD intestinal
association. Because SOD is a high-molecular-weight protein,
absorption at the small intestine is unlikely. Although gliadin
activated a tight-junction regulating protein that could increase
intestinal permeability [24], there is no evidence to support the
ability of SOD to cross the intestinal barrier.
Hereafter, the terms protected SOD, encapsulated SOD, coated
SOD, and bioactive SOD are used interchangeably and refer
to the SOD–gliadin formulation that resists gastrointestinal
inactivation.
Beneﬁcial health aspects of SOD–gliadin oral
administration
ROS have been implicated in a range of pathologies such as
cancer, cardiovascular diseases (CVDs), degenerative diseases,
and infectious diseases [7]. For many scientists studying ROS-
related disorders, the manipulation of antioxidant levels offers
the possibility to ameliorate particular conditions. Two of the
most cited publications on supplementation with melon SOD
extract are from the research groups of Xavier Leverve [25] and
Bernard Dugas [21]. In the ﬁrst study, 20 healthy volunteers were
tested to determine whether SOD combined with gliadin could
prevent cellular damage after induction of oxidative stress. The
experimental design included a daily dose of SOD–gliadin (1000Table 1
Summary of recent human research studies on SOD–gliadin dietary intake effects
Condition Model Supplementation Effects
Hyperbaric oxygen-related
cell damage
Human
(N ¼ 20)
SOD–gliadin
14 d
1000 U-NBT/d
YDNA damage
YIsoprostane blood levels
Atherosclerosis Human
(N ¼ 34)
SOD–gliadin
2 y
500 U-NBT/d
[SOD and CAT activity in
YCarotid artery IMT
YOxidative stress in blood
Fatigue Human
(N ¼ 38)
SOD–gliadin
12 wk
500 mg/d
Actinic erythema Human
(N ¼ 49)
SOD–gliadin
4 wk
YSkin redness
[Capillary network
[MED score for phototype
Intensive physical exercise Human
(N ¼ 19)
SOD–gliadin
6 wk
500 mg/d
[SOD activity in blood
YSerum levels of C-reactiv
protein
YOxidative damage in mu
CAT, catalase; GPx, glutathione peroxidase; IMT, intima media thickness; MED, min
[, increased Y, decreased.
None of the studies reported adverse side effects of oral supplementation with SOD.U SOD activity) or placebo for 14 d before exposure to 100% O2 in
a hyperbaric chamber for 60 min. Hyperbaric oxygen (HBO)
therapy is used to treat a variety of diseases, however, it also may
cause adverse effects. DNA damage is a well-documented side
effect of HBO and can be monitored using a single-cell gel elec-
trophoresis or “comet assay” [26]. Therefore, participants in this
study were tested for DNA damage, and the results showed a
signiﬁcant decrease in DNA strand breaks in the SOD–gliadin-
treated group compared with the placebo group. Additionally,
treated participants also demonstrated a diminished concen-
tration of plasma markers for oxidative stress. Other parameters,
such as SOD, CAT, and GPx activity levels in the blood remained
mainly unchanged. In the second study of melon SOD–gliadin
supplementation, Vouldoukis et al. [21] also tested the efﬁcacy of
the product as a redox modulator. For this, murine macrophages
were activated with interferon (IFN)-g and subsequently chal-
lenged with immunoglobulin (Ig) G1 immune complexes (IC) to
induce O2  production. First, the authors conﬁrmed that the
crude melon extract could demonstrate antioxidant capacity
in vitro by eliminating O2  production in activated macro-
phages in a dose-dependent manner. Moreover, cells isolated
from animals treated daily with SOD–gliadin for 28 d produced
threefold less O2  in response to IFN-g/IgG1-IC activation as
assessed by ferricytochrome C reduction. Importantly, neither
unprotected SOD nor gliadin alone could reduce oxidant pro-
duction in the same assay. Subsequently, a number of other
publications presented data examining the effects of orally active
SOD–gliadin supplementation both in experimental and clinical
research. For simplicity, these studies are grouped here by the
similarity of the model or the condition examined.
Baseline antioxidant capacity
As a proof of principle, scientists have determined whether
gliadin-coated SOD had an effect on general antioxidant defenses
in the absence of a pathologic condition. An increase in endog-
enous SOD activity was registered for mice treated with SOD–
gliadin for 28 d [15]. As expected, if mice were supplemented
with either uncoated SOD or gliadin alone, treatment had no
inﬂuence on antioxidant defenses, strengthening the idea that
the protective effect of SOD is only possible upon effectiveNo effects Other notes Study
SOD or CAT levels in blood Participants were professional
divers
[25]
blood Blood pressure or cholesterol
levels
Participants had risk factors
for atherosclerosis.
Participants also under
rigorous diet
[16]
Perceived fatigue, SOD activity
in blood or oxidative stress
SOD–gliadin activity not
tested before randomization.
Study on women (aged 50–
65 y) with longstanding
unexplained fatigue
[37]
II
Erythema clinical score Healthy participants exposed
to solar simulator
[38]
e
scle
GPx blood levels Participants were athletes
subject to 2000 m rowing
test
[39]
imal erythema dose; NBT, nitroblue tetrazolium; SOD, superoxide dismutase;
Table 2
Summary of recent animal research studies on SOD–gliadin dietary intake effects
Condition Model Supplementation Effects No effects Other notes Study
IFN-g/IgG1 IC
activated M4
C57 BL/6 mice (ex vivo
and in vivo)
SOD–gliadin
28 d
5 U-NBT/d
Y O2 - production in
cell cultures
YTNF-a in cell cultures
[IL-10 in cell cultures
n.s. [21]
Baseline healthy status Balb/c mice
(in vivo)
SOD–gliadin
28 d
0.1–5 mg/d
[SOD activity in blood
and liver
[CAT, GPx activity in
blood
[RBCs resistance to
hemolysis
YHepatocytes
apoptosis
n.s. Shows protection of
SOD–gliadin in
digestive track
mimicking conditions
[15]
Type 2 diabetes db/db mice
(in vivo)
SOD–gliadin
12 wk
YAlbumin levels in
urine
YOxidative stress in
kidney
Body weight or glucose
levels
[28]
Type 2 diabetes Wistar rats
(ex vivo and in vivo)
SOD–gliadin
4 wk
[SOD and CAT activity
in heart
[GSH levels in cardiac
muscle
YCardimyocytes
apoptosis
YLPO in plasma
n.s. Effects reported for
SOD–gliadin-treated
diabetic rats were
compared with diabetic
control animals
[29]
Ischemia/reperfusion
injury
Aortic cross-clamping
in pigs
SOD–gliadin
14 d
1250 U/d
YDNA damage
YApoptotic cells in
spinal cord
SOD, CAT, GPx levels in
blood
No ameliorated organ
function
[32]
Fibrosarcoma C57 BL/6 mice (ex vivo
and in vivo)
SOD–gliadin
30 d 10 mg/kgd1
[SOD activity in tumors
YMetastasis
development
YOxidative stress in
tumors
SOD activity in blood
Inﬁltrating cells in
tumors
Tumor incidence
Effects are lost after
intraperitoneal
administration of SOD–
gliadin.
Tendency for reduction
on tumor growth with
supplementation
[34]
Viral infection FIV-infected cats SOD–gliadin
30 d
100 mg/d
[SOD activity in blood
[CD4/CD8 ratio
GPx levels or oxidative
stress in blood
[35]
Cognitive memory C57 BL/6 mice SOD–gliadin
5 wk
100 mg/kgd1
YLPO in hippocampal
neurons
YEscape latency time
[Neurogenesis
Body weight. Only
slight increase on
hippocampal SOD
activity levels
Animal model of stress-
induced impairment of
spatial memory
[36]
CAT, catalase; FIV, feline immunodeﬁciency virus; GPx, glutathione peroxidase; IFN-g/IgG1 IC, interferon-g/immunoglobulin G1 immune complexes; IL, interleukin;
LPO, lipid peroxidation; M4, macrophage; n.s., not stated; O2 -, superoxide anion; RBC, red blood cell; SOD, superoxide dismutase; TNF, tumor necrosis factor;
[, increased Y, decreased.
None of the studies reported adverse side effects of oral supplementation with SOD.
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other antioxidant defenses such as CAT and GPx were also
increased in the plasma and livers of mice. Other assays designed
to monitor alterations in cellular resistance to oxidative stress
suggest that SOD–gliadin intake might also inﬂuence cell sur-
vival. This was shown by a decrease in hepatocyte apoptosis (20%
versus 72% in the control group) and an increased resistance to
hemolysis of erythrocytes and to mitochondrial membrane de-
polarization upon challenge with 3-morpholinosydnonimine
[15].
Metabolic disorders
Several authors have addressed bioactive SOD supplementa-
tion in the context of metabolic diseases. In the case of diabetes, a
condition that is usually associated with increased oxidative
stress, dietary antioxidants (vitamins C and E) could diminish
vascular complications without affecting blood glucose or insulin
levels [27]. One study [28] analyzed SOD–gliadin administration
in a diabetic dyslipidemia (db/db) mouse model for type 2 dia-
betes. This study focused on diabetic nephropathy, a common
complication of the disease, and revealed an overall improve-
ment in kidney function. Two lines of evidence support thisconclusion. First, there is a signiﬁcant decrease in oxidative stress
biomarkers in the kidney and urine of SOD–gliadin supple-
mented animals compared with control animals. Measurement
of 8-hydroxydeoxyguanosine, a common marker for oxidative
stress–derived DNA damage, was used to assess this. Second,
urinary albumin excretion, a risk factor for kidney failure, was
also inhibited by treatment with SOD–gliadin. Similar to other
studies, blood glucose and body weight values did not change
during treatment. A recent report using a diabetic rat model
demonstrated that SOD–gliadin treatment decreases oxidative
stress levels in heart tissue and may also reduce cardiac
apoptosis caused by diabetes [29].
Cardiovascular diseases
Several lines of evidence indicate that cardiovascular pa-
thologies are associated with ROS overproduction [30]. Results
from animal studies encouraged researchers to pursue antioxi-
dant treatment to reduce the risk for CVD. For instances, Sod1/
mutant mice, which do not exhibit cytoplasmic SOD activity,
were shown to be more susceptible to ischemia/reperfusion (I/R)
injury [31]. Interestingly, a study conducted in a porcinemodel of
aortic cross-clamping suggested that I/R-related DNA damage
S. Romao / Nutrition 31 (2015) 430–436434was reduced after pretreatment with SOD–gliadin for 2 wk [32].
Additionally, the study demonstrated a trend toward a reduction
in the number of apoptotic cells in the spinal cords of SOD–
gliadin-treated animals, in agreement with its protective effect
against I/R injury. Despite these encouraging results, an analysis
of the kidneys, a vulnerable organ during I/R, did not display the
same cell survival phenotype. This, together with a lack of evi-
dence for improved organ function, impeded the authors from
clearly conﬁrming a potential clinical use for SOD–gliadin in I/R
injury. Nonetheless, the examined parameters point toward the
use of encapsulated-SOD as a preventive auxiliary treatment,
preferably administered before surgeries involving aortic cross
clamping.
Some authors have also addressed speciﬁc vascular disorders
such as atherosclerosis. A research study on individuals at risk for
developing atherosclerosis demonstrated a striking difference
between the control and the protected SOD–supplemented
group when examining carotid thickness [16]. Individuals
receiving SOD–gliadin daily (500 U SOD activity) or placebo for a
period of 2 y were subjected to B-scan ultrasonography to
measure the intima media thickness (IMT), a standard detection
method for atherosclerotic lesions. Decreased carotid IMT mea-
surements were seen in patients after 365 d of treatment with
SOD–gliadin. Moreover, the supplemented group registered an
increase in SOD and CAT levels in the blood compared with the
placebo group. Additionally, lipid peroxidation, used as a mea-
surement of oxidative stress, was reduced after SOD–gliadin
intake. Together, these data suggest a potential role for SOD–
gliadin supplementation in the prevention of atherosclerotic
lesions, possibly through its general antioxidant action.
Inﬂammation and cancer
Chronic induction of ROS is linked to inﬂammation, which
can mediate other pathologies such as cancer [33]. Tumor cells
display reduced SOD activity and overexpression of this
enzyme can decrease malignancy [34]. A report on a mouse
model for ﬁbrosarcoma proposes that the SOD–gliadin com-
plex decreases metastasis development, which is correlated
with a reduction of oxidative stress in the tumor tissue [34]. In
this cancer model, QR-32 tumor cells and a gelatin sponge were
co-implanted to promote both inﬂammation and tumor
development in C57 BL/6 mice. In tumors from the SOD–
gliadin-treated group, SOD activity was considerably increased
(approximately twofold). However, no differences were regi-
stered for inﬂammatory cell inﬁltration at the tumor site.
Additionally, although primary tumor growth was not signiﬁ-
cantly altered, metastatic potential could be inhibited in tumor
cells derived from SOD–gliadin-treated animals. In 2004, re-
sults from a study claimed that the SOD–gliadin formulation
has anti-inﬂammatory properties [21]. The assumptions were
based on the observation that in murine models, encapsulated
SOD supplementation induced interleukin-10 production.
Up-regulation of this antiinﬂammatory cytokine also resulted
in decreased production of tumor necrosis factor-a, therefore
reducing proinﬂammatory responses.
Infection
Feline immunodeﬁciency virus (FIV) is a suitable animal
model for its human homolog, HIV/AIDS. A study aiming at
investigating the effects of melon protected SOD intake on FIV-
infected cats concluded that SOD–gliadin treatment could play
a role in preventing disease progression [35]. Although viralloads were not changed between supplemented and un-
supplemented groups, CD4/CD8 ratios increased signiﬁcantly,
indicating disease progression. Classically, FIV infection drives
CD4 T-cell depletion; thus, the effects observed after melon
coated SOD administration might possibly represent an effect of
this supplementation on the survival of CD4 Tcells. Nevertheless,
to clearly elucidate the role of melon-derived SOD intake in
infection, it is essential to await investigations in other infectious
disease models.Brain function
The effects of coated SOD ingestion on cognition are also
documented. For example, stress-induced impairment of cogni-
tive memory was alleviated by SOD–gliadin treatment in a C57
BL/6 model [36]. In these experiments, stress was induced by
physical restraint daily for 12 h over the course of 5 wk. During
this period, animals either received a normal diet or a diet sup-
plemented with SOD–gliadin. After 5 wk, lipid peroxidation in
the brain was markedly reduced with supplementation. More
importantly, spatial learning, which was affected in the control
group, improved in the SOD-treated group. Another attempt to
clarify the role of SOD administration in brain function was un-
dertaken in a study of women aged 50 to 65 y with longstanding
unexplained fatigue [37]. The women were were subjected to
SOD–gliadin supplementation or placebo for 12 wk (500 mg).
Perceived fatigue scores were registered throughout the assay by
periodic interviews. In this tested group, SOD–gliadin treatment
had no inﬂuence in fatigue-level scores. The lack of phenotype
might be explained by the absence of antioxidant activity of SOD
supplementation in this particular protocol. Indeed, the authors
stated that enzymatic activity was not measured previously to
randomization, which might have compromised the assay. For
this reason, future studies are needed to clearly elucidate the
inﬂuence of protected SOD ingestion in human fatigue and
stress.Others
The beneﬁcial effects of dietary melon SOD combined with
gliadin in other health-related areas also have been considered.
For instance, oxidative skin damage as a result of ultraviolet (UV)
exposure can be ameliorated by SOD–gliadin treatment. This was
reported in a human study where participants from different
phototypes were tested for UV-induced skin redness [38].
Compared with the control group, SOD-treated phenotype II
participants showed an increase in the minimum amount of UV
radiation needed to induce sunburn, together with a faster re-
covery from induced redness.
Sports nutrition is another area in which antioxidants have
traditionally been studied. Reports exist evaluating the effect of
SOD–gliadin supplementation on intensive physical exercise. A
clinical trial was performed during which volunteer professional
athletes were subjected to daily treatment with SOD–gliadin
(500 mg) or placebo for 6 wk [39]. In this study, blood samples
were drawn from the athletes after a 2000-m rowing exercise
test. Results showed increased SOD activity in the blood and also
demonstrated differences in certain oxidation markers in the
muscle. In addition, C-reactive protein levels were diminished in
the SOD-treated group, suggesting the activation of anti-
inﬂammatory pathways. Thus, these data show a trend toward
a beneﬁcial effect of SOD–gliadin supplementation during
intense physical activity.
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Apart from its direct capacity to detoxify O2 , oral supple-
mentation with melon SOD combined with wheat gliadin was
shown to increase endogenous antioxidant defenses. However,
experimental data deﬁning a detailed mechanism of action for
oral administration of coated SOD are yet to be presented. One
could speculate that the systemic effects reported after SOD
intake arise from a cascade of events that is initiated at the small
intestine, where SOD is released. Such events might depend on
the transactivation of transcription factors through the antioxi-
dant response element (ARE)/nuclear factor E2-related factor
(Nrf2) axis [40]. Others have hypothesized a role for nitric oxide
(NO) [36]. In this case, NO might be generated at the intestines
and later released in the blood as a response to non–self-SOD–
gliadin. Because NO is a known key biological messenger and can
freely diffuse through tissues, it is reasonable to assume that it
may also transduce the SOD–gliadin-mediated signal from the
intestine into target cells. This hypothesis has not yet been
experimentally addressed.
The ARE/Nrf2 and the NO mechanisms just mentioned also
might be related. This is supported by some evidence in the
literature that suggests that NO may modulate the expression of
antioxidant genes through the ARE/Nrf2 axis [41,42]. A recent
study hypothesized that speciﬁc genotypesmight also determine
the type of effect induced by antioxidant-rich diets [43].
Although this particular report was only performed during a
2-wk period using a limited number of volunteers, it would be
interesting to follow up on this concept.
Conclusions
Few subjects divide the scientiﬁc nutrition community as
much as antioxidant supplementation. Due to mixed results and
to the complexity of the redox pathways, it is not prudent to
generalize about beneﬁcial effects of antioxidant compounds for
all situations. The purpose of this review was to perform a
methodical analysis of recent ﬁndings on antioxidant supple-
mentation, with a speciﬁc focus on the administration of melon
SOD combined with wheat gliadin. According to peer-reviewed
published data, this particular protected melon SOD formula-
tion appears to have advantageous effects on conditions that call
for an increased expression of antioxidant enzymes. Such con-
ditions are often oxidative stress-driven pathologies like CVDs, or
special physiological situations like the practice of intensive
sports. Bioactive melon SOD oral intake might represent a
meaningful quality-of-life improvement. Additionally, it is
important to emphasize that most studies on the SOD–gliadin
formulation indicate that supplementation presents auxiliary
effects rather than curative properties. Notably, there are no re-
ports on adverse side effects of oral SOD–gliadin supplementa-
tion. Nevertheless, large-scale experimental trials should be
carried out to reinforce the recommendation for dietary intake of
gliadin-coated melon-derived SOD.
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